tradingkey.logo
搜索

Bio-Techne Corp

TECH
添加自选
44.900USD
-2.520-5.31%
收盘 05/13, 16:00美东报价延迟15分钟
7.03B总市值
63.62市盈率 TTM

Bio-Techne Corp

44.900
-2.520-5.31%

关于 Bio-Techne Corp 公司

Bio-Techne Corporation develop, manufacture and sell life science reagents, instruments and services for the research, diagnostics and bioprocessing markets worldwide. The Company’s segments include Protein Sciences segment and Diagnostics and Spatial Biology segment. The Protein Sciences segment is a developer and manufacturer of biological reagents used in all aspects of life science research, diagnostics and cell and gene therapy. The Diagnostics and Spatial Biology segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for the regulated diagnostics market, advanced tissue-based in-situ hybridization assays and instrumentation for spatial genomic and tissue biopsy analysis and genetic and oncology kits for research and clinical applications. Its product portfolio and application enable scientific investigations into biological processes and molecular diagnostics and progression of specific diseases.

Bio-Techne Corp简介

公司代码TECH
公司名称Bio-Techne Corp
上市日期Feb 09, 1989
CEOKelderman (Kim)
员工数量3100
证券类型Ordinary Share
年结日Feb 09
公司地址614 Mckinley Pl N E
城市MINNEAPOLIS
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编55413
电话16123798854
网址https://www.bio-techne.com/
公司代码TECH
上市日期Feb 09, 1989
CEOKelderman (Kim)

Bio-Techne Corp公司高管

名称
名称/职务
职务
持股
持股变动
Mr. John L. Higgins
Mr. John L. Higgins
Independent Director
Independent Director
66.88K
+2.45%
Mr. Kim Kelderman
Mr. Kim Kelderman
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
63.06K
+22.83%
Mr. Robert V. (Bob) Baumgartner, CPA
Mr. Robert V. (Bob) Baumgartner, CPA
Independent Chairman of the Board
Independent Chairman of the Board
46.50K
+3.53%
Dr. Joseph D. (Joe) Keegan, Ph.D.
Dr. Joseph D. (Joe) Keegan, Ph.D.
Independent Director
Independent Director
15.41K
+10.64%
Dr. Rupert J. Vessey, Ph.D.
Dr. Rupert J. Vessey, Ph.D.
Independent Director
Independent Director
10.99K
+14.93%
Ms. Julie L. Bushman
Ms. Julie L. Bushman
Independent Director
Independent Director
8.78K
+18.69%
Mr. Shane Bohnen
Mr. Shane Bohnen
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
5.90K
+25.73%
Dr. Judith V. Klimovsky, M.D.
Dr. Judith V. Klimovsky, M.D.
Independent Director
Independent Director
3.78K
+43.36%
Mr. James T. (Jim) Hippel
Mr. James T. (Jim) Hippel
Chief Financial Officer, Executive Vice President - Finance
Chief Financial Officer, Executive Vice President - Finance
--
--
Mr. David Clair
Mr. David Clair
Investor Relations
Investor Relations
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. John L. Higgins
Mr. John L. Higgins
Independent Director
Independent Director
66.88K
+2.45%
Mr. Kim Kelderman
Mr. Kim Kelderman
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
63.06K
+22.83%
Mr. Robert V. (Bob) Baumgartner, CPA
Mr. Robert V. (Bob) Baumgartner, CPA
Independent Chairman of the Board
Independent Chairman of the Board
46.50K
+3.53%
Dr. Joseph D. (Joe) Keegan, Ph.D.
Dr. Joseph D. (Joe) Keegan, Ph.D.
Independent Director
Independent Director
15.41K
+10.64%
Dr. Rupert J. Vessey, Ph.D.
Dr. Rupert J. Vessey, Ph.D.
Independent Director
Independent Director
10.99K
+14.93%
Ms. Julie L. Bushman
Ms. Julie L. Bushman
Independent Director
Independent Director
8.78K
+18.69%

收入明细

单位: USD更新时间: 4月6日 周一
单位: USD更新时间: 4月6日 周一
FY2026Q2
FY2026Q1
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2021
FY2020
FY2019
业务USD
名称
营收
占比
Consumables
235.44M
79.57%
Instruments
29.61M
10.01%
Service
22.32M
7.54%
Royalty
8.51M
2.88%
地区USD
名称
营收
占比
United States
146.56M
49.53%
EMEA, excluding U.K
75.35M
25.47%
Greater China
26.35M
8.91%
APAC, excluding Greater China
22.74M
7.69%
United Kingdom
13.73M
4.64%
Rest of World
11.14M
3.77%
业务
地区
业务USD
名称
营收
占比
Consumables
235.44M
79.57%
Instruments
29.61M
10.01%
Service
22.32M
7.54%
Royalty
8.51M
2.88%

股东统计

更新时间: 5月11日 周一
更新时间: 5月11日 周一
持股股东
股东类型
持股股东
持股股东
占比
Vanguard Capital Management, LLC
6.50%
BlackRock Institutional Trust Company, N.A.
5.84%
Vanguard Portfolio Management, LLC
4.14%
State Street Investment Management (US)
3.71%
Wellington Management Company, LLP
3.66%
其他
76.15%
持股股东
持股股东
占比
Vanguard Capital Management, LLC
6.50%
BlackRock Institutional Trust Company, N.A.
5.84%
Vanguard Portfolio Management, LLC
4.14%
State Street Investment Management (US)
3.71%
Wellington Management Company, LLP
3.66%
其他
76.15%
股东类型
持股股东
占比
Investment Advisor
60.05%
Investment Advisor/Hedge Fund
37.12%
Hedge Fund
9.13%
Research Firm
2.58%
Bank and Trust
1.97%
Pension Fund
1.77%
Sovereign Wealth Fund
1.08%
Individual Investor
0.30%
Insurance Company
0.23%

机构持股

更新时间: 4月5日 周日
更新时间: 4月5日 周日
报告期
机构数
持股数
持股占比
持股变动
2026Q1
1247
178.19M
113.81%
+1.43K
2025Q4
1230
172.60M
110.32%
+3.07M
2025Q3
1198
161.18M
103.53%
-7.34M
2025Q2
1209
165.25M
105.41%
-730.33K
2025Q1
1245
168.10M
107.22%
+1.54M
2024Q4
1233
162.21M
102.61%
-6.39M
2024Q3
1205
159.40M
100.49%
-10.21M
2024Q2
1207
160.52M
101.86%
-12.24M
2024Q1
1216
162.56M
103.40%
-7.57M
2023Q4
1229
159.70M
100.98%
-3.97M
查看更多

股东持股明细

名称
持股数
占比
持股变动
变动比例
公告日期
BlackRock Institutional Trust Company, N.A.
9.14M
5.84%
+350.80K
+3.99%
Dec 31, 2025
State Street Investment Management (US)
5.81M
3.71%
+58.64K
+1.02%
Dec 31, 2025
Wellington Management Company, LLP
5.73M
3.67%
+618.92K
+12.10%
Dec 31, 2025
Geode Capital Management, L.L.C.
4.93M
3.15%
+2.62K
+0.05%
Dec 31, 2025
Atlanta Capital Management Company, L.L.C.
4.83M
3.08%
-115.50K
-2.34%
Dec 31, 2025
MFS Investment Management
3.91M
2.5%
+2.46M
+169.79%
Dec 31, 2025
Maverick Capital, Ltd.
3.85M
2.46%
+838.27K
+27.82%
Dec 31, 2025
T. Rowe Price Associates, Inc.
3.85M
2.46%
+725.05K
+23.23%
Dec 31, 2025
查看更多

持股ETF

更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
Global X Genomics & Biotechnology ETF
4.29%
Invesco Biotechnology & Genome ETF
2.92%
Invesco S&P 500 Equal Weight Health Care ETF
2%
Neuberger Berman Small-Mid Cap ETF
1.78%
VanEck Biotech ETF
1.73%
Hilton Small-MidCap Opportunity ETF
1.7%
iShares Health Innovation Active ETF
1.68%
American Century Mid Cap Growth Impact ETF
1.47%
Thrivent Small-Mid Cap ESG ETF
1.34%
Invesco S&P 500 High Beta ETF
1.06%
查看更多
Global X Genomics & Biotechnology ETF
占比4.29%
Invesco Biotechnology & Genome ETF
占比2.92%
Invesco S&P 500 Equal Weight Health Care ETF
占比2%
Neuberger Berman Small-Mid Cap ETF
占比1.78%
VanEck Biotech ETF
占比1.73%
Hilton Small-MidCap Opportunity ETF
占比1.7%
iShares Health Innovation Active ETF
占比1.68%
American Century Mid Cap Growth Impact ETF
占比1.47%
Thrivent Small-Mid Cap ESG ETF
占比1.34%
Invesco S&P 500 High Beta ETF
占比1.06%

分红派息

近5年累计派现 250.90M 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
May 06, 2026
TECH.NB Interim Cash Dividend of gross USD 0.08 paid on May 29, 2026 going ex on May 18, 2026
May 18, 2026
May 29, 2026
May 18, 2026
Feb 04, 2026
TECH.NB Final Cash Dividend of gross USD 0.08 paid on Feb 27, 2026 going ex on Feb 13, 2026
Feb 16, 2026
Feb 27, 2026
Feb 13, 2026
Nov 05, 2025
TECH.NB Interim Cash Dividend of gross USD 0.08 paid on Nov 28, 2025 going ex on Nov 17, 2025
Nov 17, 2025
Nov 28, 2025
Nov 17, 2025
Aug 06, 2025
TECH.NB Interim Cash Dividend of gross USD 0.08 paid on Aug 29, 2025 going ex on Aug 18, 2025
Aug 18, 2025
Aug 29, 2025
Aug 18, 2025
May 07, 2025
TECH.NB Interim Cash Dividend of gross USD 0.08 paid on May 30, 2025 going ex on May 19, 2025
May 19, 2025
May 30, 2025
May 19, 2025
Feb 05, 2025
TECH.NB Final Cash Dividend of gross USD 0.08 paid on Feb 28, 2025 going ex on Feb 14, 2025
Feb 17, 2025
Feb 28, 2025
Feb 14, 2025
Oct 30, 2024
TECH.NB Interim Cash Dividend of gross USD 0.08 paid on Nov 22, 2024 going ex on Nov 08, 2024
Nov 11, 2024
Nov 22, 2024
Nov 08, 2024
Aug 07, 2024
TECH.NB Interim Cash Dividend of gross USD 0.08 paid on Aug 30, 2024 going ex on Aug 19, 2024
Aug 19, 2024
Aug 30, 2024
Aug 19, 2024
May 01, 2024
TECH.NB Interim Cash Dividend of gross USD 0.08 paid on May 24, 2024 going ex on May 10, 2024
May 13, 2024
May 24, 2024
May 10, 2024
Feb 01, 2024
TECH.NB Final Cash Dividend of gross USD 0.08 paid on Feb 26, 2024 going ex on Feb 09, 2024
Feb 12, 2024
Feb 26, 2024
Feb 09, 2024
查看更多

拆合股

公告日期
除权除息日
类型
比率
Nov 01, 2022
Split
1→4
公告日期
除权除息日
类型
比率
Nov 01, 2022
Split
1→4
KeyAI